Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Accounts Payables (2024 - 2025)

Carlsmed (CARL) has disclosed Accounts Payables for 2 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 85.78% year-over-year to $4.5 million, compared with a TTM value of $4.5 million through Dec 2025, up 85.78%, and an annual FY2025 reading of $4.5 million, up 85.78% over the prior year.
  • Accounts Payables was $4.5 million for Q4 2025 at Carlsmed, up from $2.7 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $4.5 million in Q4 2025 and bottomed at $2.4 million in Q4 2024.